SCHEMBL7445356

SCHEMBL7445356

CC(C)CNS(=O)(=O)c1ccc(N)nc1

nearest known ligand 0.55

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.55
ALOX5AP P20292 3/20 0.51
FEN1 P39748 3/20 0.51
KDM4E B2RXH2 1/20 0.50
LMNA P02545 1/20 0.48
GAA P10253 1/20 0.48
HPGD P15428 1/20 0.48
GBA1 P04062 1/20 0.47
TP53 P04637 1/20 0.46
CA1 P00915 4/20 0.44
CA2 P00918 4/20 0.44
TSHR P16473 1/20 0.43
PKM P14618 1/20 0.41
KMT2A Q03164 1/20 0.41
POLB P06746 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7686760 0.90 ALOX5AP (0.55) ALDH1A1ALOX5APFEN1LMNAGAA
SCHEMBL6790764 0.80 ALDH1A1 (0.67) ALDH1A1GAAHPGDGBA1CA1
SCHEMBL11629219 0.77 KDM4E (0.53) ALOX5APFEN1KDM4EGAATP53
SCHEMBL890706 0.75 ALDH1A1 (0.61) ALDH1A1GAAHPGDGBA1CA1
SCHEMBL3997838 0.74 KDM4E (0.58) ALOX5APFEN1KDM4EGAA
SCHEMBL7862567 0.74 GBA1 (0.74) ALDH1A1GAAHPGDGBA1CA1
SCHEMBL23092657 0.73 KDM4E (0.53) ALDH1A1ALOX5APFEN1KDM4ELMNA
SCHEMBL20946436 0.73 ALDH1A1 (0.73) ALDH1A1LMNAGAAHPGDGBA1
SCHEMBL29715407 0.73 KDM4E (0.53) ALDH1A1ALOX5APFEN1KDM4ELMNA
SCHEMBL30513193 0.73 ALDH1A1 (0.56) ALDH1A1ALOX5APFEN1KDM4EKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0946528-A2 OXYGEN OR SULFUR CONTAINING 5-MEMBERED HETEROAROMATICS AS FACTOR Xa INHIBITORS Du Pont Pharmaceuticals Company (US) 1999-10-06 EP disclosed
WO-1998028282-A2 OXYGEN OR SULFUR CONTAINING 5-MEMBERED HETEROAROMATICS AS FACTOR Xa INHIBITORS DU PONT PHARMACEUTICALS COMPANY (US) 1998-07-02 WO disclosed